ABVX

ABVX

USD

Abivax SA American Depositary Shares

$98.640-0.160 (-0.162%)

Precio en Tiempo Real

Healthcare
Biotecnología
Francia

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$98.800

Máximo

$104.986

Mínimo

$98.540

Volumen

0.88M

Fundamentos de la Empresa

Capitalización de Mercado

8.2B

Industria

Biotecnología

País

France

Estadísticas de Negociación

Volumen Promedio

1.09M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $4.77Actual $98.640Máximo $108

Noticias Relacionadas

GlobeNewswire

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative

Ver más
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis